Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: results of the DYSlipidemia International Study (DYSIS).

L. A. Leiter, P. Lundman, P. M. da Silva, H. Drexel, C. Jünger, A. K. Gitt, , Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study Diabetic Medicine. ,vol. 28, pp. 1343- 1351 ,(2011) , 10.1111/J.1464-5491.2011.03360.X

Jiang He, Dongfeng Gu, Xigui Wu, Kristi Reynolds, Xiufang Duan, Chonghua Yao, Jialiang Wang, Chung-Shiuan Chen, Jing Chen, Rachel P. Wildman, Michael J. Klag, Paul K. Whelton, Major Causes of Death among Men and Women in China The New England Journal of Medicine. ,vol. 353, pp. 1124- 1134 ,(2005) , 10.1056/NEJMSA050467

, Z. Reiner, A. L. Catapano, G. De Backer, I. Graham, M.-R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M. J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P. P. Filardi, G. Riccardi, R. F. Storey, D. Wood, J. Bax, A. Vahanian, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, G. Filippatos, C. Funck-Brentano, D. Hasdai, R. Hobbs, A. Hoes, P. Kearney, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, A. Torbicki, P. Vardas, P. Widimsky, S. Windecker, D. Reviewers:, C. Funck-Brentano, D. Poldermans, G. Berkenboom, J. De Graaf, O. Descamps, N. Gotcheva, K. Griffith, G. F. Guida, S. Gulec, Y. Henkin, K. Huber, Y. A. Kesaniemi, J. Lekakis, A. J. Manolis, P. Marques-Vidal, L. Masana, J. McMurray, M. Mendes, Z. Pagava, T. Pedersen, E. Prescott, Q. Rato, G. Rosano, S. Sans, A. Stalenhoef, L. Tokgozoglu, M. Viigimaa, M. E. Wittekoek, J. L. Zamorano, , , ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)☆☆☆ Atherosclerosis. ,vol. 32, pp. 1769- 1818 ,(2011) , 10.1093/EURHEARTJ/EHR158

Nadeem Sarwar, John Danesh, Gudny Eiriksdottir, Gunnar Sigurdsson, Nick Wareham, Sheila Bingham, S. Matthijs Boekholdt, Kay-Tee Khaw, Vilmundur Gudnason, Triglycerides and the Risk of Coronary Heart Disease 10 158 Incident Cases Among 262 525 Participants in 29 Western Prospective Studies Circulation. ,vol. 115, pp. 450- 458 ,(2007) , 10.1161/CIRCULATIONAHA.106.637793

Bi-lian Yu, Shui-ping Zhao, Dao-quan Peng, Yong Huo, Lu Hu, A comparison of non-HDL and LDL cholesterol goal attainment in the CHILLAS trial. International Journal of Cardiology. ,vol. 168, pp. 4340- 4342 ,(2013) , 10.1016/J.IJCARD.2013.05.080

Jennifer G. Robinson, Songfeng Wang, Brian J. Smith, Terry A. Jacobson, Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk Journal of the American College of Cardiology. ,vol. 53, pp. 316- 322 ,(2009) , 10.1016/J.JACC.2008.10.024

Anselm K. Gitt, Claus Jünger, Wenefrieda Smolka, Kurt Bestehorn, Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany. Clinical Research in Cardiology. ,vol. 99, pp. 723- 733 ,(2010) , 10.1007/S00392-010-0177-Z

Jean-Charles Fruchart, Frank M Sacks, Michel P Hermans, Gerd Assmann, W Virgil Brown, Richard Ceska, M John Chapman, Paul M Dodson, Paola Fioretto, Henry N Ginsberg, Takashi Kadowaki, Jean-Marc Lablanche, Nikolaus Marx, Jorge Plutzky, Zeljko Reiner, Robert S Rosenson, Bart Staels, Jane K Stock, Rody Sy, Christoph Wanner, Alberto Zambon, Paul Zimmet, The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients Diabetes and Vascular Disease Research. ,vol. 5, pp. 319- 335 ,(2008) , 10.3132/DVDR.2008.046

David J Maron, Pamela M Hartigan, David R Neff, William S Weintraub, William E Boden, COURAGE Trial Investigators, Impact of adding ezetimibe to statin to achieve low-density lipoprotein cholesterol goal (from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation [COURAGE] trial). American Journal of Cardiology. ,vol. 111, pp. 1557- 1562 ,(2013) , 10.1016/J.AMJCARD.2013.02.005

Jenie Yoonoo Hwang, Chang Hee Jung, Woo Je Lee, Cheol Young Park, Sung Rae Kim, Kun-Ho Yoon, Moon Kyu Lee, Sung Woo Park, Joong-Yeol Park, Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes Diabetes & Metabolism Journal. ,vol. 35, pp. 628- 636 ,(2011) , 10.4093/DMJ.2011.35.6.628